CHMP2B mutations are also implicated in neurodegenerative disorders, including FTLD, progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) [50] (Table 1). Here, CHMP2B is linked to supranuclear palsy, progressive, 1.